UK Markets close in 7 hrs 32 mins

Fresenius SE & Co. KGaA (FRE.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
29.35+0.21 (+0.72%)
As of 05:35PM CEST. Market open.
Full screen
Previous close29.14
Bid29.33 x N/A
Ask29.35 x N/A
Day's range29.13 - 29.71
52-week range26.52 - 47.60
Avg. volume1,065,206
Market cap19.481B
Beta (5Y monthly)1.27
PE ratio (TTM)9.50
EPS (TTM)3.09
Earnings date21 Feb 2022 - 25 Feb 2022
Forward dividend & yield0.92 (2.76%)
Ex-dividend date16 May 2022
1y target est45.50
  • Reuters

    Fresenius plans to cut 2,000 jobs globally at Kabi unit - Handelsblatt

    In Germany, 250 jobs would be affected, the paper said. Fresenius, which runs dialysis centers and hospitals, makes generic drugs and helps plan hospital construction projects, last year launched a group-wide cost cutting programme to become more competitive amid a declining share price over several years.

  • Reuters

    Fresenius warns of bigger Ukraine war impact after Q1 profit beat

    German healthcare group Fresenius's first-quarter profit exceeded market expectations on Wednesday, driven by growth in its generic infusion drugs unit in emerging markets. However, the group warned cost inflation and supply chain disruptions were likely to increase this year, fuelled by Russia's invasion of Ukraine. Fresenius's businesses include the Helios hospital chain, drugmaker Kabi, medical services firm Vamed and dialysis specialist Fresenius Medical Care (FMC).

  • Zacks

    Omnicell (OMCL) Inks New Deal to Manage Controlled Substances

    Omnicell (OMCL), Fresenius Kabi collaborate to offer safe and efficient dispensing of controlled substances across hospitals and health systems in the United States.